✦ LIBER ✦

P.247 Prediction of treatment outcome in genotype 4 chronic hepatitis C patients during combined pegylated interferon alpha-2a and ribavirin therapy (ANRS 1211 trial)

✍ Scribed by G. Esmat; H. ElMakhzangy; S. Males; R.R. Gad; C. Rekacewicz; S.A. Ismail; M. Abdel-Hamid; M. El-Daly; S. Pol; A. Fontanet; M.K. Mohamed

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

559 Combined pegylated interferon α-2a a

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 126 KB

314 Randomized Controlled Trial of Pegyl

✍ Lam, Khoa D.; Trinh, Huy N.; Do, Son T.; Nguyen, Thuan T.; Garcia, Ruel T.; Nguy 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Combination treatment of alpha interfero

✍ ELZAYADI, A 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Enhanced efficacy of pegylated interfero

✍ Sanaa M. Kamal; Amany Ahmed; Sara Mahmoud; Leila Nabegh; Iman El Gohary; Isi Oba 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

Effective prediction of outcome of combi

✍ Hideyuki Nomura; Yugo Miyagi; Hironori Tanimoto; Masashi Higashi; Hiromi Ishibas 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 391 KB

Prediction of nonSVR to therapy with peg

✍ E. Lukasiewicz; M. Gorfine; L. S. Freedman; J.-M. Pawlotsky; S. W. Schalm; C. Fe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB